CYP2B6 c.171+1352T>C

Variant ID: 19-41498733-T-C

NM_000767.4(CYP2B6):c.171+1352T>C

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

The Pharmacogenomics Journal
Choi, Jihoon J; Tantisira, Kelan G KG; Duan, Qing Ling QL
Publication Date: 2019-04

Variant appearance in text: rs6508963
PubMed Link: 30214008
Variant Present in the following documents:
  • NIHMS1503453-supplement-3.xlsx, sheet 1
View BVdb publication page



Polymorphisms in cytochrome P450 are associated with extensive efavirenz pharmacokinetics and CNS toxicities in an HIV cohort in Botswana.

The Pharmacogenomics Journal
Vujkovic, Marijana M; Bellamy, Scarlett L SL; Zuppa, Athena F AF; Gastonguay, Marc R MR; Moorthy, Ganesh S GS; Ratshaa, Bakgaki B; Han, Xiaoyan X; Steenhoff, Andrew P AP; Mosepele, Mosepele M; Strom, Brian L BL; Bisson, Gregory P GP; Aplenc, Richard R; Gross, Robert R
Publication Date: 2018-09

Variant appearance in text: rs6508963
PubMed Link: 29855606
Variant Present in the following documents:
  • Main text
  • nihms959883.pdf
View BVdb publication page



Analysis of pharmacogenetic traits in two distinct South African populations.

Human Genomics
Ikediobi, Ogechi O; Aouizerat, Bradley B; Xiao, Yuanyuan Y; Gandhi, Monica M; Gebhardt, Stefan S; Warnich, Louise L
Publication Date: 2011-05

Variant appearance in text: rs6508963
PubMed Link: 21712189
Variant Present in the following documents:
  • Main text
View BVdb publication page